Skip to main content
Log in

Changes of pharmacokinetics of 6,7-dimethoxycoumarin in a rat model of alpha-naphthylisothiocyanate-induced experimental hepatic injury after Yinchenhao Decoction (茵陈蒿汤) treatment

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To study the changes of pharmacokinetics of 6,7-dimethoxycoumarin in a rat model of alpha-naphthylisothiocyanate (ANIT)-induced experimental hepatic injury after oral administration of Yinchenhao Decoction (茵陈蒿汤, YCHD) using an ultra pressure liquid chromatography (UPLC) method.

Methods

Rats were divided into a normal group and a model group, after modeled by 4% ANIT (75 mg/kg) for 48 h, they were orally administrated with YCHD extract at the dose of 0.324 g/kg, and then blood was collected from their orbital sinus after different intervals. Changes in liver function were monitored by the levels of liver enzymes [alanine aminotransferase (ALT), aspartate aminotransferase (AST)] and bilirubins [total bilirubin (TBIL), direct bilirubin (DBIL)], the concentration of 6,7-dimethoxycoumarin in plasma were measured by UPLC, and the pharmaceutical parameters were calculated with DAS2.1.1 software.

Results

The concentration-time curve of both normal and modeled rats after oral administration of YCHD was obtained. Their time to maximum plasma concentration (tmax) were both 0.25 h, the maximum concentration (Cmax) were 4.533 μg/mL and 6.885 μg/mL, and their area under concentration-time curve (AUC)0→24h were 16.272 and 32.981, respectively. There was a 51.88% and 100.46% increase in Cmax and AUC0-t (P<0.05), but there showed a 45.52% and 92.93% reduction in clearance of drug and volum of distribution (P<0.05), respectively.

Conclusions

Hepatic injury could significantly influence the pharmacokinetics of 6,7-dimethoxycoumarin after oral administration of YCHD, the absorption and distribution process was accelerated in liver injured rats, but the metabolism and elimination process was slowed. And this may lead to a significant accumulation of 6,7-dimethoxycoumarin in the body.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Itoh T, Shibahara N, Mantani N, Tahara E, Shimada Y, Terasawa K. Effect of Kampo treatment on chronic viral hepatitis on the basis of traditional diagnosis. J Tradit Med 1997;14:204–210.

    Google Scholar 

  2. Onji M, Kikuchi T, Michitaka K, Yamashita K, Ohta Y. Combined use of ursodeoxycholic acid and Inchinko-to in jaundice patients with primary biliarycirrhosis. J Med Pharmaceut 1990;7:161–167.

    Google Scholar 

  3. Arai M, Yokosuka O, Fukai K, Kanda T, Kojima H, Kawai S, et al. A case of severe acute hepatitis of unknown etiology treated with the Chinese herbal medicine Inchinko-to. Hepatol Res 2004;28:161–165.

    Article  PubMed  Google Scholar 

  4. Liu YJ, Li Z, Lin ZB. Scoparone’s effects on the airway smooth muscle of asthmatic guinea pigs. J Chin Med Univ (Chin) 2001;30(Suppl):12–13.

    Google Scholar 

  5. Yuan X, Li Z, Liu HR, Yu XH, Han LW. Inhibitory effect of scoparone on airway inflammation and enhanced ROS of asthmatic models of guinea pigs. J Chin Med Univ (Chin) 2002;31:404–406.

    CAS  Google Scholar 

  6. He L, Yang S, Wu D, Cui T, Wei D, Ding Z. Coumarins from Skimmia arborescens and its anti-inflammatory effect. China J Chin Mater Med (Chin) 2012;37:811–813.

    Google Scholar 

  7. Wang XJ, Li YL, Sun H. Hepatoprotective effects of Yinchenhao Tang and its constituent absorbed into blood after oral administration. Chin Pharmacol Bull (Chin) 2004;20:239–240.

    CAS  Google Scholar 

  8. Chen J, Wang SM, Wang K, Ji S. Determination of 6,7-dimethoxycoumarin in rat plasma by LC-MS/MS method. Chin J Health Lab Tech (Chin) 2011;2:306–308.

    Google Scholar 

  9. Fang Y, Li Z, Watanabe Y. Pharmacokinetics of a novel antiasthmatic, scoparone, in the rabbit serum assessed by a simple HPLC method. J Ethnopharmacol 2003;86:127–130.

    Article  PubMed  CAS  Google Scholar 

  10. Yin Q, Sun H, Zhang A, Wang X. Pharmacokinetics and tissue distribution study of scoparone in rats by ultraperformance liquid-chromatography with tandem highdefinition mass spectrometry. J Fitoterapia 2012;83:795–800.

    Article  CAS  Google Scholar 

  11. Shunichi T, Shunzaburo I, Takashi N, Hisaaki K, Iman Z, Raman V, et al. The influence of liver dysfunction on cyclosporine pharmacokinetics—a comparison between 70 percent hepatectomy and complete bile duct ligation in dog. Jpn J Surg 1989;19:49–56.

    Article  Google Scholar 

  12. Kahan BD. Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation 1985;40:457–476.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hai-long Yuan  (袁海龙).

Additional information

Supported by the National Natural Science Foundation of China (No. 81073069)

LU Jun-lan and LI Rui-sheng contributed equally to this work

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lv, Jl., Li, Rs., Jin, Sy. et al. Changes of pharmacokinetics of 6,7-dimethoxycoumarin in a rat model of alpha-naphthylisothiocyanate-induced experimental hepatic injury after Yinchenhao Decoction (茵陈蒿汤) treatment. Chin. J. Integr. Med. 18, 831–836 (2012). https://doi.org/10.1007/s11655-012-1272-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-012-1272-8

Keywords

Navigation